Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Comment to the position paper on global recommendations for the management of dyslipidemia developed by the International Atherosclerosis Society (IAS).

Catapano AL, Chapman MJ, de Backer G, Taskinen MR, Reiner Z, Wiklund O.

Atherosclerosis. 2014 Apr;233(2):508-9. doi: 10.1016/j.atherosclerosis.2013.12.050. Epub 2014 Jan 21. No abstract available.

PMID:
24530786
2.

An International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia: executive summary.

Expert Panel on Dyslipidemia.

Atherosclerosis. 2014 Feb;232(2):410-3. doi: 10.1016/j.atherosclerosis.2013.11.031. Epub 2013 Nov 28. Review. No abstract available.

PMID:
24468156
3.

International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia.

Barter P.

Clin Investig Arterioscler. 2014 Jan-Feb;26(1):21-2. doi: 10.1016/j.arteri.2013.09.004. Epub 2013 Dec 12. No abstract available.

PMID:
24332604
4.

An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia.

Expert Dyslipidemia Panel, Grundy SM.

J Clin Lipidol. 2013 Nov-Dec;7(6):561-5. doi: 10.1016/j.jacl.2013.10.001. Epub 2013 Oct 22. Review.

PMID:
24314355
5.

An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia--full report.

Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members.

J Clin Lipidol. 2014 Jan-Feb;8(1):29-60. doi: 10.1016/j.jacl.2013.12.005. Epub 2013 Dec 17.

PMID:
24528685
6.

[Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary].

IAS Panel for Global Recommendations for the Management of Dyslipidemia, Grundy SM, Arai H, Barter P, Bersot TP, Betteridge DJ, Carmena R, Cuevas A, Davidson MH, Genest J, Kesäniemi YA, Sadikot S, Santos RD, Susekov A, Sy R, Tokgozoglu L, Watts GF, Zhao D; International Society of Atherosclerosis.

Clin Investig Arterioscler. 2014 Jan-Feb;26(1):33-7. doi: 10.1016/j.arteri.2013.09.005. Epub 2013 Oct 26. Spanish. No abstract available.

PMID:
24169377
7.

[International Atherosclerosis Society guidelines for management of dyslipidemia].

Millán Núñez-Cortés J.

Clin Investig Arterioscler. 2014 Jan-Feb;26(1):20. doi: 10.1016/j.arteri.2013.09.003. Epub 2013 Oct 16. Spanish. No abstract available.

PMID:
24139446
8.

[Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidelines related to the diagnostics and treatment of dyslipidemias issued in 2011].

Soška V, Vaverková H, Vráblík M, Bláha V, Cífková R, Freiberger T, Kraml P, Piťha J, Rosolová H, Stulc T, Urbanová Z.

Vnitr Lek. 2013 Feb;59(2):120-6. Czech.

PMID:
23461401
9.

[Decalogue of clinical recommendations on atherogenic dyslipidemia].

Pedro-Botet J, Millán J, Brea Á, Díaz Á, González-Santos P, Hernández-Mijares A, Mantilla T, Pintó X, Simó R.

Clin Investig Arterioscler. 2014 Jan-Feb;26(1):38-40. doi: 10.1016/j.arteri.2013.11.007. Epub 2013 Dec 21. Spanish. No abstract available.

PMID:
24365580
10.

[Prevention and treatment of atherosclerosis and cardiovascular diseases].

Knobler H, Bitzur R, Gavish D, Rubinstein A, Henkin Y, Chajek-Shaul T, Harats D.

Harefuah. 2012 May;151(5):281-8, 319, 318. Hebrew.

PMID:
22844732
11.

Management of dyslipidemia in the elderly population.

Gobal FA, Mehta JL.

Ther Adv Cardiovasc Dis. 2010 Dec;4(6):375-83. doi: 10.1177/1753944710385048. Epub 2010 Oct 21. Review.

PMID:
20965950
12.

National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary.

Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, McKenney JM, Grundy SM, Gill EA, Wild RA, Wilson DP, Brown WV.

J Clin Lipidol. 2014 Sep-Oct;8(5):473-88. doi: 10.1016/j.jacl.2014.07.007. Epub 2014 Jul 15.

13.

From the Maastricht meeting to the European Atherosclerosis Society Consensus on phytosterols/phytostanols: what is new of an old story?

Zampelas A.

Atherosclerosis. 2014 Apr;233(2):357-8. doi: 10.1016/j.atherosclerosis.2014.01.007. Epub 2014 Jan 19. No abstract available.

PMID:
24530762
14.

[The new 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk: comparison with the ESC/EAS recommendations for the management of dyslipidemias].

Catapano AL, Averna M, Faggiano P, Novo S.

G Ital Cardiol (Rome). 2014 Jan;15(1):19-20. doi: 10.1714/1394.15514. Italian. No abstract available.

PMID:
24503730
15.

[New european guidelines for dyslipidemia].

Riesen WF, Virgini V, Vogt B, Rodondi N.

Rev Med Suisse. 2012 Mar 7;8(331):525-6, 528-30. French.

PMID:
22471115
16.

Management of inherited atherogenic dyslipidemias in children.

Guardamagna O, Cagliero P, Abello F.

Ther Apher Dial. 2013 Apr;17(2):150-61. doi: 10.1111/j.1744-9987.2012.01146.x. Epub 2012 Dec 16. Review.

PMID:
23551671
17.

American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis.

Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA; AACE Task Force for Management of Dyslipidemia and Prevention of Atherosclerosis.

Endocr Pract. 2012 Mar-Apr;18 Suppl 1:1-78. No abstract available.

PMID:
22522068
18.

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Perrone Filardi P, Riccardi G, Storey RF, Wood D; ESC Committee for Practice Guidelines 2008-2010 and 2010-2012 Committees.

Atherosclerosis. 2011 Jul;217 Suppl 1:S1-44. doi: 10.1016/j.atherosclerosis.2011.06.012. Review. No abstract available. Erratum in: Atherosclerosis. 2011 Jul;217(1):2.

PMID:
21723445
19.

American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary.

Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA; AACE Task Force for Management of Dyslipidemia and Prevention of Atherosclerosis.

Endocr Pract. 2012 Mar-Apr;18(2):269-93. No abstract available.

PMID:
22507559
20.

ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman M, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D; European Society of Cardiology (ESC); European Atherosclerosis Society (EAS).

Atherosclerosis. 2011 Jul;217(1):3-46. Review. No abstract available.

PMID:
21882396

Supplemental Content

Support Center